Screener
Haemonetics HAE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $3.41B.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's market capitalization?
- Haemonetics (HAE) reported market capitalization of $3.41B in Q2 2026.
- How has Haemonetics's market capitalization changed year-over-year?
- Haemonetics's market capitalization decreased by 2.9% year-over-year, from $3.51B to $3.41B.
- What is the long-term trend for Haemonetics's market capitalization?
- Over 5 years (2021 to 2026), Haemonetics's market capitalization has grown at a -14.3% compound annual growth rate (CAGR), from $5.67B to $2.62B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Haemonetics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude